Physician profile
Kevin E Potts
NPI 1750366605
$1,059.08
in general payments reported to CMS, 2019-2025
20 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $103 · 2021: $44.83 · 2022: $29.85 · 2023: $161 · 2024: $157 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $206.99 | 2019-2025 | Tezspire, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.34 | 2019-2023 | |
| Glaxosmithkline, LLC. | $112.53 | 2019-2025 | Trelegy Ellipta, Nucala |
| Acclarent, INC | $103.11 | 2020 | |
| Insmed, INC. | $88.40 | 2021-2025 | Brinsupri, Arikayce |
| Genzyme Corporation | $71.45 | 2025 | |
| Verona Pharma, INC. | $49.34 | 2025 | Ohtuvayre |
| Novo Nordisk INC | $38.65 | 2025 | Wegovy |
| Viatris Specialty LLC | $33.75 | 2025 | Yupelri |
| Grifols USA, LLC | $29.58 | 2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $24.88 | 2025 | Dupixent |
| Ani Pharmaceuticals, INC. | $24.05 | 2025 | Purified Cortrophin Gel |
| Radiometer America, INC | $20.33 | 2023 | |
| Philips North America LLC | $19.31 | 2019 | |
| Pulmonx Corporation | $16.38 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $15.88 | 2019 | |
| Electromed, INC. | $13.88 | 2019 | |
| Circassia INC. | $13.14 | 2019 | |
| Shire North American Group INC | $12.39 | 2019 | |
| Sunovion Pharmaceuticals INC. | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Potts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.